Jefferies Maintains Hold on Abbott Laboratories, Raises Price Target to $125
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Matthew Taylor maintains a Hold rating on Abbott Laboratories (NYSE:ABT) and raises the price target from $120 to $125.
October 17, 2024 | 1:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies analyst Matthew Taylor maintains a Hold rating on Abbott Laboratories and raises the price target from $120 to $125.
The increase in price target from $120 to $125 suggests a positive outlook on Abbott Laboratories' stock, which may lead to a slight upward movement in the stock price. However, the Hold rating indicates a neutral stance, suggesting limited short-term upside.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100